Home Healthcare IT Global Facial Rejuvenation Market Size, Trends Forecast to 2029 |

Facial Rejuvenation Market

Facial Rejuvenation Market Size, Share & Trends Analysis Report By Product Type (Botulinum Toxin, Dermal Fillers, Chemical Peels, Topical Skin Care Products, Skin Rejuvenation Devices), By Mode of Treatment (Drugs, Injectables, Surgical means, Others),  By End-User (Hospitals and Clinics, Dermatology Clinics, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI1291DR
Study Period 2020-2032 CAGR 3.0%
Historical Period 2020-2022 Forecast Period 2024-2032
Base Year 2023 Base Year Market Size USD XX Billion
Forecast Year 2032 Forecast Year Market Size USD XX Billion
Largest Market North America Fastest Growing Market Asia Pacific
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The Global Facial Rejuvenation Market size was valued at USD 1985 million in 2019 and is expected to grow at 3.0% CAGR during the forecast period.

Facial rejuvenation is a medical cosmetic treatment procedure that is aimed to restore the youthful physical appearance of the face. These facial rejuvenation techniques can be either surgical or non-surgical and can be used for the treatment of static wrinkles, freckles, dynamic wrinkles, vascular conditions, scars and wounds, and pigmentation. Naturally, with the process of aging, the facial skin loses subcutaneous fat, and thus, is pulled closer to the facial working muscles, resulting in smile lines and wrinkles over the face. These issues can be rectified by using facial rejuvenation products such as injectables or dermal fillers which are provenly effective in treating early signs of aging.

 

Market Dynamics

The Growing Geriatric and Middle-Aged Population and Rising Beauty Consciousness Is Driving the Market Globally

There has been a growing number of people across the globe who belong to the middle-aged and geriatric age bracket. These people are recognized as the most frequent consumers of market products. Thus, the growing number of people in the aforementioned age bracket generates huge demand for market products. For instance, according to reports suggested by Eurostat, the median age in Europe is 42.5 years in 2020 that rose from constant 41.7 years in 2019, 2018, and 2017 respectively. Further, statistics suggest that around 66.4 percent between the ages of 15 and 64 years in Mexico. Further, as per Statistics Canada, 40-43% of the population is estimated to be in the age bracket of 25-54 years.

Table 1: The U.S. Population Demographics Projection Data (65 Years and Over): 2020 to 2060

Year of Estimate

Total population 65 years and over (number in thousands)

Native-born population 65 years and over (number in thousands)

Foreign-born population 65 years and over

2020

56,052

48,034

8,017

2030

73,138

60,849

12,289

2040

80,827

64,268

16,559

2050

85,675

65,838

19,837

2060

94,676

72,652

22,024

**Source: 2020 to 2060; National Population Projections2017.

Thus, as per projections, since a huge number of estimated people are expected to be in the age bracket of 65years and older in the coming future, it can be predicted that a major proportion of people currently belong to the age group of 45-60 years. Thus, quite evidently, the market is projected to be significantly boosted during the study period owing to such a consumer base.

The High Rate of Adoption Coupled with Growing Efforts to Launch Advanced Products Is a Major Market Driver

During the past few years, there has been rising adoption of cosmetic facial rejuvenation techniques. This is primarily due to growing beauty consciousness among consumers, growing need to maintain physical presentability. Further, there is a huge number of professionals in professions that demand long-lasting youthful appearances especially in the facial regions such as actors, dancers, models, sportsmen, and others.

Table 2: Total Surgical Aesthetic Procedures across the Globe During 2019-2018

Total Surgical Procedures

2019

2018

Percent Change 2019 Vs. 2018

Brow Lift

270,917

220,055

23.1%

Ear Surgery

288,905

262,078

10.2%

Eyelid Surgery

1,259,839

1,099,960

14.5%

Facelift

448,485

398,798

12.5%

Facial Bone Contouring

108,536

98,727

9.9%

Fat Grafting-face

598,823

542,305

10.4%

Facial Rejuvenation

4,058,143

3,574,408

13.5%

*Source: International Society of Aesthetic Plastic Surgery; Global Survey 2019

Table 3: Total Non-Surgical Aesthetic Procedures across the Globe During 2019-2018

Total Surgical Procedures

2019

2018

Percent Change 2019 Vs. 2018

Chemical Peel

369,497

408,485

-9.5%

Full Field Ablative

190,978

192,880

-1.0%

Micro-Ablative Resurfacing

270,759

201,797

34.2%

Photo Rejuvenation

391,415

436,656

-10.4%

Total Facial Rejuvenation

1,222,648

1,239,819

-1.4%

*Source: International Society of Aesthetic Plastic Surgery; Global Survey 2019

Thus, owing to the aforementioned factors there has been a growing number of aesthetic enhancement procedures that ultimately boost the market.

Further, the market growth is also fueled owing to continuous efforts from market players to launch new products as well as strategies to penetrate unexplored markets. For instance, InMode MD Ltd. has been conducting a clinical trial on energy-based lower eyelid rejuvenation using its novel InModeAccuTite device expected to be completed by 2021.

 

Regional Analysis

America Dominates the Global Market in Terms of Revenue Generation

The American regional market contributes a significant number to the global revenue. This is because there is a huge number of professionals within the region who are active in show businesses such as Actors, dancers, models, sportsmen, and others. Further, the presence of the Hollywood industry in the region that worth in billion operates on aesthetics, generates huge demands for these market products and contributes significantly to totals spending on cosmetic products.

Additionally, high disposable income, growing beauty among common people, and the increasing importance of physical appearance in presentability are other drivers of the market. The majority of the regional population has a high average income which makes this facial rejuvenation and medical aesthetics products affordable, which is also predicted to boost the market growth. For instance, as per the American Society for Aesthetic Plastic Surgery (ASAPS), Americans invested around USD 13500 million on aesthetic procedures in 2015 and further an estimated amount of more than USD 15000 million in 2016. Further, the great number of aesthetic procedures that are carried out in the region boosts the regional market.

Table 4: Total Number of Aesthetic Non-surgical Procedures in the Americas in 2019

Treatment Category

USA

BRAZIL

MEXICO

ARGENTINA

Botulinum Toxin

1,301,823

507,869

287,420

76,802

Calcium Hydroxylapatite

37,881

29,694

14,762

3,971

Hyaluronic Acid

679,167

398,830

170,515

61,831

Chemical Peel

73,347

34,804

14,783

3,201

Full Field Ablative

30,360

15,088

10,047

3,234

Micro-Ablative Resurfacing

69,621

12,503

9,962

3,234

Total Facial Rejuvenation Procedure

276,069

86,438

58,580

31,405

*Source: International Society of Aesthetic Plastic Surgery; Global Survey 2019

APAC Market to Witness a Considerably High Growth Rate during the Forecast Period

Asia-Pacific market is expected to show high growth during the aforementioned market forecast period. The market growth is predominantly owing to the shifting focus to better facial aesthetics and appearance among people. The people with these growing beauty concerns can be traced to the mid-age population and elderly age brackets. Thus, the pronounced presence of the aforementioned population segment is driving the facial rejuvenation market in Asia-Pacific. For instance, it is estimated that approximately 48.42% of the total population of China was aged between 25 to 54 years with the highest numbers in Shanghai and Beijing. Further, the growing number of facial rejuvenation procedures in the region is also significantly boosting the regional market.

Further, owing to the presence of a huge population such as China and India, these countries are often targeted markets for global market leaders. For instance, market leaders Allergans launched Juvederm Volite Dermal Filler in India on January 19th, 2020 targeting to explore a huge population and thus, consumer base in the Indian Market. Further, in October 2019, InMode Ltd. has successfully established two new subsidiaries in the Asia-Pacific region namely; InMode India and InMode Australia.

Table 5: Total cosmetic non-surgical treatments conducted in India (2019)

Injectables

Number of Procedures

% Of Total Global

Total Injectables Procedures

113,616

45.6%

Total Facial Rejuvenation Procedures

80,304

32.2%

*Source: International Society of Aesthetic Plastic Surgery; Global Survey 2019

Report Scope

Report Metric Details
Segmentations
By Product Type
  1. Botulinum Toxin
  2. Dermal Fillers
    1. Hyaluronic acid
    2. Polymers
    3. Calcium hydroxyapatite
    4. Collagen
  3. Chemical Peels
  4. Topical Skin Care Products
  5. Skin Rejuvenation Devices
    1. Ablative laser treatments
    2. Ultrasound
    3. Others
By Mode of Treatment
  1. Drugs
  2. Injectables
  3. Surgical means
  4. Others
 By End-User
  1. Hospitals and Clinics
  2. Dermatology Clinics
  3. Others
Company Profiles Allergan (Ireland) Merz Pharma (Germany) Galderma (Switzerland) Lumenis (The U.S.) Revance (The U.S.) Contura Ltd (The U.S.) Anika Therapeutics, Inc. (The U.S.) Fibrocell Science, Inc. (The U.S.) Sinclair Pharma (U.K.) Suneva Medical (The U.S.) SciVision Biotech Inc. (Taiwan)
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

By Product, Dermal Fillers Segment Dominates the Global Market

Within the global facial rejuvenation market, the dermal filler product segment generates the highest revenue amongst others. This market dominance can be attributed to the fact that, when compared to traditional cosmetic surgeries, these fillers are proven to be more reliable, easy-going, affordable, and cost-effective. For instance, according to the American Society of Plastic Surgeons, in the year 2018, the basic fees charged by cosmetic or plastic surgeons for a facelift surgery was at an aggregate of USD 7655, whereas, the cost of the same using dermal fillers such as hyaluronic acid was estimated to be approximately USD 682 in the U.S. Thus, quite naturally, there is an increasing the bias towards the adoption of dermal fillers.

Further, most of the consumers are very aware and conscious about the products they use, and hence towing to this, many consumers prefer prescription-based facial rejuvenation products such as dermal fillers that have clinically proven record for safety and effectiveness. Thus, there has been an increase in the adoption of these products that are enhancing the growth of the facial rejuvenation market.

Among End-Users, Dermatology Clinics Dominate the Global Market

By End-users, the Dermatology clinics segment market is expected to hold the majority of the market and is further anticipated to progress at a steady pace over the projected timeframe. This high growth projectile is primarily due to the high preference among consumers to opt for these clinics. Further, these clinics provide generous treatment options and thus witness fueled growth.

However, the hospitals and clinics segment is anticipated to demonstrate the highest growth rate owing to the increasing consumer pool who seek these treatments. Thus, owing to the presence of large spaces and supporting infrastructure, a greater number of trained personnel, the segment is witnessing growth.

Market Size By Product Type

Recent Developments

  • In December 2019, Daewoong Pharmaceutical, a market player based in South Korea, had received approval for its botulinum toxin product, Nabota, from The Ministry of Health in the UAE and Indonesia’s Badan PengawasObat dan Makanan for launch.
  • In April 2019, Lumenis launched new skin rejuvenating technology Legend Pro+ for skin tightening and wrinkle reduction.

Top Key Players

Allergan (Ireland) Merz Pharma (Germany) Galderma (Switzerland) Lumenis (The U.S.) Revance (The U.S.) Contura Ltd (The U.S.) Anika Therapeutics, Inc. (The U.S.) Fibrocell Science, Inc. (The U.S.) Sinclair Pharma (U.K.) Suneva Medical (The U.S.) SciVision Biotech Inc. (Taiwan) Others

Frequently Asked Questions (FAQs)

What is the growth rate for the Facial Rejuvenation Market?
Facial Rejuvenation Market size will grow at approx. CAGR of 3% during the forecast period.
Some of the top industry players in Facial Rejuvenation Market are, Allergan (Ireland), Merz Pharma (Germany), Galderma (Switzerland), Lumenis (The U.S.), Revance (The U.S.), Contura Ltd (The U.S.), Anika Therapeutics, Inc. (The U.S.), Fibrocell Science, Inc. (The U.S.), Sinclair Pharma (U.K.), Suneva Medical (The U.S.), SciVision Biotech Inc. (Taiwan), etc.
North America has been dominating the Facial Rejuvenation Market, accounting for the largest share of the market.
The Facial Rejuvenation Market has seen the most substantial growth rate in Asia Pacific.
The global Facial Rejuvenation Market report is segmented as follows: By Product Type, By Mode of Treatment, By End-User


We are featured on :